Generex Biotechnology Corporation, through its subsidiary, Hema Diagnostic Systems, LLC, focuses on the development, manufacture, and distribution of in-vitro medical diagnostics for infectious diseases in Canada and the United States. The company offers Rapid Diagnostic Tests for human immunodeficiency virus?½ w/p24Ab, tuberculosis-XT, malaria, hepatitis, syphilis, typhoid, dengue, and other infectious diseases. Generex Biotechnology Corporation was founded in 1983 and is based in Miramar, Florida.
Industry, Sector and Symbol
Stock Exchange OTCMKTS
Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:GNBT
CUSIPN/A
Phone416-364-2551
Debt
Debt-to-Equity RatioN/A
Current Ratio0.07
Quick Ratio0.07
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash Flow$63.4615 per share
Price / Cash0.13
Book Value($74.78) per share
Price / Book-0.11
Profitability
EPS (Most Recent Fiscal Year)N/A
Net Income$-70,010,000.00
Net MarginsN/A
Return on EquityN/A
Return on Assets-166.13%
Miscellaneous
Employees12
Outstanding Shares1,070,000
Market Cap$2.45 million
Generex Biotechnology (OTCMKTS:GNBT) Frequently Asked Questions
What is Generex Biotechnology's stock symbol?
Generex Biotechnology trades on the OTCMKTS under the ticker symbol "GNBT."
When is Generex Biotechnology's next earnings date?
Who are some of Generex Biotechnology's key competitors?
Some companies that are related to Generex Biotechnology include Parnell Pharmaceuticals (PARNF), Peak Pharmaceuticals (PKPH), Concordia International (CXRX), International Stem Cell (ISCO), Sonoma Pharmaceuticals (SNOA), Ritter Pharmaceuticals (RTTR), Reliv International (RELV), Sunwin Stevia International (SUWN), Flex Pharma (FLKS), ContraVir Pharmaceuticals (CTRV), MYOS (MYOS), Immune Therapeutics (IMUN), Stellar Biotechnologies (SBOT), Apricus Biosciences (APRI) and Pain Therapeutics (PTIE).
Who are Generex Biotechnology's key executives?
Generex Biotechnology's management team includes the folowing people:
- Mr. Joseph Moscato, Chief Exec. Officer, Pres and Director (Age 54)
- Mr. Mark Corrao, CFO & Treasurer (Age 59)
- Mr. Andrew Ro, Chief Investment Officer, Sr. VP of Investments & Director (Age 47)
- Mr. Mark A. Fletcher Esq., Exec. VP, Gen. Counsel & Sec. (Age 53)
- Mr. Richard D. Purcell, Sr. VP of Research & Drug Devel. (Age 57)
How do I buy shares of Generex Biotechnology?
Shares of GNBT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Generex Biotechnology's stock price today?
One share of GNBT stock can currently be purchased for approximately $8.25.
How big of a company is Generex Biotechnology?
Generex Biotechnology has a market capitalization of $2.45 million. Generex Biotechnology employs 12 workers across the globe.
What is Generex Biotechnology's official website?
How can I contact Generex Biotechnology?
Generex Biotechnology's mailing address is 10102 USA TODAY WAY, MIRAMAR FL, 33025. The company can be reached via phone at 416-364-2551 or via email at [email protected]
MarketBeat Community Rating for Generex Biotechnology (OTCMKTS GNBT)
MarketBeat's community ratings are surveys of what our community members think about Generex Biotechnology and other stocks. Vote "Outperform" if you believe GNBT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GNBT will underperform the S&P 500 over the long term. You may vote once every thirty days.
